Development Level

Tchem 4 | 1,890
Tbio 3 | 10,625
Tclin 1 | 602

IMPC Term

increased circulating alanine ... 2 | 11
increased circulating aspartat... 2 | 17
abnormal behavior 1 | 226
abnormal lung morphology 1 | 15
abnormal retina morphology 1 | 100
decreased circulating serum al... 1 | 79
increased circulating HDL chol... 1 | 63
increased circulating alkaline... 1 | 119
increased circulating choleste... 1 | 53
increased circulating potassiu... 1 | 31
increased circulating triglyce... 1 | 24
increased lactate dehydrogenas... 1 | 3
increased lean body mass 1 | 107
preweaning lethality, complete... 1 | 633
preweaning lethality, incomple... 1 | 260

Disease

lung cancer 4 | 4,466
osteosarcoma 4 | 7,933
ovarian cancer 4 | 8,484
Cancer 3 | 2,346
Cholestasis 3 | 93
Liver disease 3 | 219
interstitial cystitis 3 | 2,299
lung adenocarcinoma 3 | 2,713
non-small cell lung cancer 3 | 2,798
ulcerative colitis 3 | 2,087
Cholestasis of pregnancy 2 | 5
Intrahepatic cholestasis 2 | 19
Leber congenital amaurosis 2 | 72
Metabolic syndrome X 2 | 155
Multiple myeloma 2 | 1,327
Waldenstrons macroglobulinemia 2 | 765
cutaneous lupus erythematosus 2 | 1,056
glioblastoma 2 | 5,572
hepatocellular carcinoma 2 | 532
mucosa-associated lymphoid tissue lymphoma 2 | 480
psoriasis 2 | 6,685
Afibrinogenemia 1 | 4
Attention deficit hyperactivity disorder 1 | 156
Bilirubin metabolic disorder 1 | 39
Bipolar Disorder 1 | 266
Blastic phase chronic myeloid leukemia 1 | 58
Breast cancer 1 | 3,094
Calculus in biliary tract 1 | 2
Cardiovascular system disease 1 | 194
Cholangitis 1 | 20
Cholelithiasis 1 | 14
Cholelithiasis Prevention 1 | 1
Cholestasis, benign recurrent intrahepatic 2 1 | 1
Chronic Lymphocytic Leukemia 1 | 242
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Chronic phase chronic myeloid leukemia 1 | 45
Colorectal Neoplasms 1 | 217
Crohn Disease 1 | 97
Diabetes mellitus type 2 1 | 69
Drug-Induced Liver Injury 1 | 118
Extravasation of Diagnostic and Therapeutic Materials 1 | 6
Fatty liver disease 1 | 84
Fragile X syndrome 1 | 31
Gout 1 | 93
Hepatitis B 1 | 103
Hepatitis D 1 | 10
IGA Glomerulonephritis 1 | 454
Intestinal Neoplasms 1 | 11
Keratoconjunctivitis sicca 1 | 19
Liver Cirrhosis, Experimental 1 | 108
Liver carcinoma 1 | 217
Liver diseases 1 | 66
Liver neoplasms 1 | 109
Lupus erythematosus 1 | 80
Multiple Sclerosis 1 | 498
Obesity 1 | 616
Ornithine carbamoyltransferase deficiency 1 | 13
Parkinson's disease 1 | 364
Peripheral Neuropathy 1 | 303
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 1 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 1 | 47
Prevention of Cardiac Transplant Rejection 1 | 14
Prevention of Kidney Transplant Rejection 1 | 16
Prevention of Liver Transplant Rejection 1 | 14
Primary biliary cirrhosis 1 | 43
Primary cholangitis 1 | 2
Progressive intrahepatic cholestasis (disorder) 1 | 3
Pruritus 1 | 6
Rheumatoid Arthritis 1 | 1,160
Schizophrenia 1 | 501
Sclerosing cholangitis 1 | 16
Severe Recalcitrant Psoriasis 1 | 11
Tear film insufficiency 1 | 14
Tularemia 1 | 22
Type 2 diabetes mellitus 1 | 189
active Crohn's disease 1 | 918
acute myeloid leukemia 1 | 780
aldosterone-producing adenoma 1 | 664
astrocytoma 1 | 1,493
breast carcinoma 1 | 1,614
chronic lymphosyte leukemia 1 | 232
colon cancer 1 | 1,475
cystic fibrosis 1 | 1,665
diabetes mellitus 1 | 1,663
group 3 medulloblastoma 1 | 2,254
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
invasive ductal carcinoma 1 | 2,950
lung carcinoma 1 | 2,844
nephrosclerosis 1 | 329
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511
pre-eclampsia 1 | 67
primary Sjogren syndrome 1 | 789
sarcoidosis 1 | 358
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,557
urothelial carcinoma 1 | 318

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Respiratory system 8 | 17,484
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444

Target Family

Enzyme 2 | 4,146
Transporter 2 | 473
Epigenetic 1 | 242
Kinase 1 | 634
Non-IDG 1 | 11,971
Nuclear Receptor 1 | 48

Grant Application

7R01DK084434-26 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 RPN1 Tbio Enzyme -2.12744 139.1 249
Bile acid receptor NR1H4 Tclin Nuclear Receptor -2.48530 306.4 272
Sodium/bile acid cotransporter SLC10A1 Tchem Transporter -2.56506 411.8 149
Histone-arginine methyltransferase CARM1 CARM1 Tchem Epigenetic -1.98286 118.4 453
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 DAD1 Tbio Enzyme -2.56095 357.9 192
Tyrosine-protein kinase Fgr FGR Tchem Kinase -2.34266 216.3 353
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Bile salt export pump ABCB11 Tchem Transporter -2.77114 639.9 130